Results 91 to 100 of about 874,057 (168)
Recent Advances in Localized Scleroderma
Localized scleroderma (LSc), or morphea, is an autoimmune connective tissue disease causing inflammation and fibrosis of the skin and underlying tissues. While distinct from systemic sclerosis, its clinical presentation is highly diverse.
Toshiya Takahashi +2 more
doaj +1 more source
Localized scleroderma: A rare clinical entity
Localized Scleroderma (LS), which is also referred to as morphea, is an inflammatory disease that leads to diffuse or localized fibrotic and atrophic skin hardening.
Ravneet Arora +2 more
core +1 more source
Localized scleroderma: case report and literature review. [PDF]
Background. Localized scleroderma is a rare chronic autoimmune inflammatory disorder, belonging to the spectrum of sclerosing skin diseases, affecting patients of any age, more frequently Caucasian females.
Pargaliauskaitė, Julija,
core
Background. Timely verification of the clinical diagnosis of connective tissue diseases in children based on the onset of the earliest symptoms, including skin manifestations, and timely initiation of treatment can prevent the development of irreversible
Anastasia O. Zatolokina +3 more
doaj +1 more source
Scleroderma in children: An update
PURPOSE OF REVIEW: Scleroderma, in its localized and systemic presentation, represents the third most frequent rheumatic condition in childhood after juvenile idiopathic arthritis and systemic lupus erythematosus.
Cuffaro, Giorgio +2 more
core +1 more source
Articular involvement in juvenile localized scleroderma [PDF]
Osminina MK, Geppe NA, Shpitonkova OV
openaire +1 more source
Methotrexate and Mycophenolate Mofetil and Clinical Response in Juvenile Localized Scleroderma
Importance Currently, there are no treatments approved by the US Food and Drug Administration for juvenile localized scleroderma (JLS), a rare disease. While methotrexate (MTX) is regularly used as a first-line therapy, emerging data from case series and applications in systemic sclerosis suggest that ...
de Rosas, Elena C. +3 more
openaire +2 more sources
Juvenile scleroderma (JS) is a group of diseases characterized byincreased skin thickness and fibrosis. It is the third-most commonrheumatic condition in childhood.
Colussi, Lara +5 more
core +1 more source
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, necessitating further cellular and molecular level studies.
Theresa Hutchins +17 more
core +1 more source

